Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Multiple pharmacological effects reported by Egis for new AMPA receptor antagonists

March 31, 1999

Nonpeptide tachykinin antagonists: preparation and use described by Lilly

March 31, 1999

Landmark study demonstrates successful example of gene therapy for pain control

March 31, 1999

Bristol-Myers Squibb drops antimigraine drug from the pipeline

March 30, 1999

Suntory's neuroprotective compound SUN-N4057 is effective in rat models

March 30, 1999

Novel series from Egis with muscle relaxant, neuroprotective and anticonvulsant activity

March 29, 1999

Structurally distinct 5-HT ligands for depression, anxiety discovered at SB

March 29, 1999

Cognition-enhancing activity of ipidacrine is comparable to that of donepezil in preclinical model

March 26, 1999

5-HT7 antagonist DR-4004 shows anxiolytic efficacy in murine model

March 26, 1999

Phase II results reported for RSD-921 at ASCPT meeting

March 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...